- Adjuvant Treatment Required during Survivorship Following Surgery and Chemotherapy for Colorectal Cancer
-
Lee JY
- KMID: 2563749
- J Dig Cancer Res.
- 2024 Dec;12(3):234-236.
- doi: 10.52927/jdcr.2024.12.3.234
-
- CITED
-
- Close
- SHARE
-
- Close
- Systematic Review and Meta-analysis in Digestive Cancer Research
-
Gwon SH, Son NH
- KMID: 2563745
- J Dig Cancer Res.
- 2024 Dec;12(3):207-215.
- doi: 10.52927/jdcr.2024.12.3.207
This article highlights the role of meta-analysis as a statistical method for quantitatively summarizing existing research and reconciling conflicting findings. It discusses literature search methods for meta-analysis, the selection and... -
- CITED
-
- Close
- SHARE
-
- Close
- Emerging Prospects for Combining Immune Checkpoint Inhibitors with Loco-regional Therapy in Hepatocellular Carcinoma
-
Cho EY, Lee CH, Kim IH
- KMID: 2563748
- J Dig Cancer Res.
- 2024 Dec;12(3):229-233.
- doi: 10.52927/jdcr.2024.12.3.229
-
- CITED
-
- Close
- SHARE
-
- Close
- Dental Considerations for Patients Undergoing Chemotherapy
-
Kang ES
- KMID: 2563744
- J Dig Cancer Res.
- 2024 Dec;12(3):195-206.
- doi: 10.52927/jdcr.2024.12.3.195
Even with the advances in chemotherapeutic procedures and agents, chemotherapy may cause certain side effects that impair patients’ quality of life. Cancer treatment can lead to various other side effects,... -
- CITED
-
- Close
- SHARE
-
- Close
- Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma
-
Kim Y
- KMID: 2563738
- J Dig Cancer Res.
- 2024 Dec;12(3):145-152.
- doi: 10.52927/jdcr.2024.12.3.145
Endoscopic submucosal dissection (ESD) is a predominantly used technique for superficial esophageal cancer treatment. The primary advantages of esophageal ESD include its high en bloc resection rate and the precise... -
- CITED
-
- Close
- SHARE
-
- Close
- Post-colonoscopy Colorectal Cancer: Causes and Prevention
-
Lee JY
- KMID: 2563740
- J Dig Cancer Res.
- 2024 Dec;12(3):160-170.
- doi: 10.52927/jdcr.2024.12.3.160
Post-colonoscopy colorectal cancer (PCCRC), classified as colorectal cancer (CRC) diagnosed following a negative colonoscopy and prior to the recommended follow-up; despite advancements in the quality of colonoscopy, remains a significant... -
- CITED
-
- Close
- SHARE
-
- Close
- Robotic Gastrectomy for Gastric Cancer: A Review of Postoperative and Oncologic Outcomes
-
Kim YM
- KMID: 2563739
- J Dig Cancer Res.
- 2024 Dec;12(3):153-159.
- doi: 10.52927/jdcr.2024.12.3.153
Robotic gastrectomy is a promising alternative to laparoscopic surgery for gastric cancer. This review examines the indications and the short-term surgical and long-term oncologic results of robotic gastrectomy. The indications... -
- CITED
-
- Close
- SHARE
-
- Close
- Realistic Approach to Elevated Carbohydrate Antigen 19-9
-
Jeong HT, Han J
- KMID: 2563741
- J Dig Cancer Res.
- 2024 Dec;12(3):171-175.
- doi: 10.52927/jdcr.2024.12.3.171
Carbohydrate antigen 19-9 (CA 19-9) is a tumor marker initially identified from colorectal cancer cell lines and is currently widely used in the diagnosis and monitoring of pancreatic and biliary... -
- CITED
-
- Close
- SHARE
-
- Close
- Metabolic Dysfunction-associated Steatotic Liver Disease– related Hepatocellular Carcinoma: Current Research Insights
-
Chun HS, Lee M, Kim TH
- KMID: 2563743
- J Dig Cancer Res.
- 2024 Dec;12(3):184-194.
- doi: 10.52927/jdcr.2024.12.3.184
The global increase in the incidence of metabolic disorders is increasing the burden of nonalcoholic fatty liver disease (NAFLD) progression and NAFLD-related hepatocellular carcinoma (HCC) development; urgent measures are required... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between Metabolic Factors and Gastric Cancer
-
Nam SY, Kwon OK, Jeon SW
- KMID: 2563746
- J Dig Cancer Res.
- 2024 Dec;12(3):216-223.
- doi: 10.52927/jdcr.2024.12.3.216
Background/Aims: We investigated sex- and stage-specific associations of body mass index (BMI), fasting glucose, and high-density lipoprotein cholesterol (HDL-C) with gastric cancer. Methods: In total, 3,382 patients with gastric cancer and... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in Immunotherapy and Targeted Therapy for Biliary Tract Cancer
-
Lee JW, Kang H
- KMID: 2563742
- J Dig Cancer Res.
- 2024 Dec;12(3):176-183.
- doi: 10.52927/jdcr.2024.12.3.176
Biliary tract cancer (BTC) is a rare malignancy with increasing incidence and mortality over the past two decades. Despite its unique anatomical and molecular features, BTC is typically diagnosed at... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis and Treatment of Imatinib-induced Pneumonitis in a Patient with High-risk Rectal Gastrointestinal Stromal Tumor
-
Kim SJ, Lee J
- KMID: 2563747
- J Dig Cancer Res.
- 2024 Dec;12(3):224-228.
- doi: 10.52927/jdcr.2024.12.3.224
Imatinib is a well-established targeted therapeutic agent for gastrointestinal stromal tumors (GISTs), acting as a key tyrosine kinase inhibitor. Despite its clinical efficacy, imatinib is associated with a variety of... -
- CITED
-
- Close
- SHARE
-
- Close
